News

SmithKline Beecham fined in Hungary

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7120.1397l (Published 29 November 1997) Cite this as: BMJ 1997;315:1397
  1. Carl Kovac
  1. Budapest

    SmithKline Beecham Pharmaceuticals has been fined one million Hungarian florints (£3065) by the Hungarian Consumer Protection Authority and ordered to withdraw advertisements that promote vaccinations against hepatitis B.

    The advertisements started appearing in August in magazines targeted at teenagers and on television. According to the national public health commissioner, Ilona Molnár, the advertisements exaggerated the …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe